E.U. Finalizes €500M In Grants, Loans For COVAX Advanced Market Commitment; U.K. Spending On Vaccines Reaches Nearly £12B; ACT Faces $28B Funding Shortfall, WHO Says
Devex: E.U. finalizes €500M boost for COVAX
“The European Union signed over a promised €100 million ($122 million) grant and €400 million loan to Gavi, the Vaccine Alliance Tuesday, reinforcing efforts to ensure people in low- and middle-income countries have swift access to a COVID-19 vaccine. The money will be channeled through Gavi’s COVAX Advanced Market Commitment, which is working to make 1 billion vaccine doses available to people in 92 LMICs. The AMC is financed mainly through official development assistance, and philanthropic and private sector contributions…” (Chadwick/Ravelo, 12/16).
Financial Times: U.K. spending on Covid vaccines hits nearly £12bn, watchdog says
“The U.K.’s push to secure and administer hundreds of millions of doses of coronavirus vaccines is estimated to have cost up to £11.7bn so far, according to the public spending watchdog. The government has signed deals for five vaccines providing up to 267m doses at an expected cost of £2.9bn, with non-binding agreements with two other companies set to bring total provision to 357m doses, the National Audit Office said in a report published on Wednesday…” (Mancini, 12/15).
Reuters: New kinds of loans and bonds could fill $28 billion COVID funding gap: WHO
“The World Health Organization is looking at new financial instruments to help to fill a $28 billion funding shortfall for tools to fight COVID-19, a senior official said on Tuesday. … Bruce Aylward, a senior WHO adviser and its ACT coordinator, said that new financing mechanisms — including concessional loans and catastrophe bonds — were discussed at a meeting of the ACT facilitation council on Monday, co-chaired by Norway and South Africa…” (Nebehay/Farge, 12/15).
U.N. News: To end the pandemic, WHO says $28 billion ACT project is ‘the best deal in town’
“An international coalition aiming to tackle the COVID-19 pandemic needs $28 billion, a bargain price for stopping the damage done by a virus that has run rampant for the past year, a senior U.N. World Health Organization (WHO) official said on Tuesday. … The group has three big targets, Dr. Aylward said: two billion doses of vaccines at least by the end of 2021, 500 million new rapid diagnostics for low- and middle-income countries, and 250 million therapeutic tests…” (12/15).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.